O’Neill, S. ., Bidulka, P. ., Lugo-Palacios, D. G., Carroll, O. ., Leiva-Escobar, I. ., Silverwood, R. ., … Grieve, R. . (2025). Comparative effectiveness of alternative second-line oral glucose-lowering therapies for type 2 diabetes: a precision medicine approach applied to routine data. Diabetologia. http://doi.org/10.1007/s00125-025-06447-x
diabetes mellitus
Pasea, L. ., Mohamed, M. ., Dashtban, A. ., Bhuva, A. ., Mizani, M. A., Ali, S. ., … Banerjee, A. . (2025). Missed opportunities to manage complex comorbidity of heart failure, type 2 diabetes mellitus and chronic kidney disease: a retrospective cohort study. Heart. http://doi.org/10.1136/heartjnl-2024-325046
Lugo-Palacios, D. G., Bidulka, P. ., O’Neill, S. ., Carroll, O. ., Basu, A. ., Adler, A. ., … Grieve, R. . (2024). Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populations. Health Econ. http://doi.org/10.1002/hec.4903
Jones, T. ., Patel, R. ., Elwenspoek, M. M. C., Watson, J. C., Mann, E. ., Alsop, K. ., & Whiting, P. F. (2023). Variation in laboratory testing for patients with long-term conditions: a longitudinal cohort study in UK primary care. BJGP Open. http://doi.org/10.3399/bjgpo.2022.0139
Weiss, T. ., Yang, L. ., Carr, R. D., Pal, S. ., Sawhney, B. ., Boggs, R. ., … Iglay, K. . (2022). Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK. BMJ Open Diabetes Res Care, 10. http://doi.org/10.1136/bmjdrc-2021-002517